Mark For: TECHNOLOGY FOR THE GENOME® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76291341 |
Registration Number | 2619149 |
Mark Literal Elements | TECHNOLOGY FOR THE GENOME |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | March 25, 2002 |
Affidavit Text | PARTIAL SECT 8 (6-YR). |
Current Location | Not Found 2009-03-11 |
Basis | 1(a) |
Class Status | SECTION 8 - CANCEL |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Cancellation Code | 2 |
Attorney Name | ANN LAMPORT HAMMITTE |
Law Office Assigned | M60 |
Employee Name | SMITH, BRIDGETT G |
2001-01-01 | Date of First Use |
2001-03-01 | Date of Use In Commerce |
2001-07-26 | Application Filed |
2002-03-25 | Amend to Register |
2002-09-10 | Trademark Registered |
2009-03-11 | Location: |
2009-03-11 | Location: Not Found |
2013-04-12 | Cancelled |
2013-04-12 | Status: Dead/Cancelled |
2013-04-12 | Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | 940 WINTER STREET WALTHAM, MASSACHUSETTS UNITED STATES 02451 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | 2001-07-26 | |
![]() | 2001-07-26 | |
![]() | 2001-07-26 | |
![]() | 2002-03-25 | |
![]() | 2002-09-10 | |
![]() | IMAGE/TIFF | 2002-09-10 |
![]() | 2003-08-12 | |
![]() | 2003-09-17 | |
![]() | 2006-09-08 | |
![]() | 2006-09-08 | |
![]() | 2007-11-28 | |
![]() | 2007-11-28 | |
![]() | 2007-11-28 | |
![]() | 2007-11-28 | |
![]() | 2009-03-02 | |
![]() | 2009-03-11 |
(CANCELLED)
IC 001. US 001 005 006 010 026 046. G & S: Chemical products for scientific and research use, namely, nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses. FIRST USE: 20010101. FIRST USE IN COMMERCE: 20010301(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: [ Pharmaceutical products for clinical and medical use, namely, nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses; diagnostic medical reagents for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer, comprised of reagents, processing chemicals, and solid matrix materials ]. FIRST USE: 20010101. FIRST USE IN COMMERCE: 20010301(CANCELLED)
IC 009. US 021 023 026 036 038. G & S: Scientific measuring apparatus and instruments, namely, substrate chips used in the measurement of biopolymers and biological samples; genomic arrays, namely, arrays spotted with artificial chromosomes, oligomers, and cDNA clones; arrays, namely, arrays of polypeptides, nucleic acids and proteins on substrates for use in genomic analysis; biochips used for genomic hybridization, genomic profiling, DNA copy number estimation, gene duplication and detection, and transcript factor comparisons; computer hardware and software for analyzing images for analysis of biopolymers and biological samples and related user manuals. FIRST USE: 20010101. FIRST USE IN COMMERCE: 20010301(CANCELLED)
IC 042. US 100 101. G & S: [ Testing and analysis of biopolymers and biological samples for others; design for others of customized substrate chips used in the measurement of biopolymers and biological samples; design of customized arrays for others; providing technical support, namely, troubleshooting customer problems with scientific measuring apparatus and instruments, namely, substrate chips used in the measurement of biopolymers and biological samples; providing technical support, namely, troubleshooting customer problems with hardware and software for analyzing images used for analysis of biopolymers and biological samples ]. FIRST USE: 20010101. FIRST USE IN COMMERCE: 20010301
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Chemical products for scientific and research use, namely, nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses |
Description | Date | Proceeding Number |
---|---|---|
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2013-04-12 | |
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | 2009-03-11 | 59807 |
ASSIGNED TO PARALEGAL | 2009-03-06 | 59807 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2009-03-04 | |
REGISTERED - SEC. 8 (6-YR) FILED | 2009-03-02 | |
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2009-03-02 | |
PAPER RECEIVED | 2009-03-02 | |
CASE FILE IN TICRS | 2007-12-05 | |
REVIEW OF CORRESPONDENCE COMPLETE | 2006-09-18 | 74215 |
PAPER RECEIVED | 2006-09-08 | |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2006-08-02 | |
REVIEW OF CORRESPONDENCE COMPLETE | 2005-08-20 | 68502 |
FAX RECEIVED | 2003-09-17 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2003-08-12 | |
REGISTERED-SUPPLEMENTAL REGISTER | 2002-09-10 | |
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2002-06-03 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-03-28 | |
PAPER RECEIVED | 2002-03-25 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-02-19 | |
NON-FINAL ACTION MAILED | 2001-09-21 | |
ASSIGNED TO EXAMINER | 2001-09-07 | 76582 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.